FDA OKs Novavax COVID-19 Vaccine as First Booster Shot

THURSDAY, Oct. 20, 2022 (HealthDay News) – On Wednesday, the U.S. Food and Drug Administration approved the Novavax Inc. protein-based vaccine as a first booster dose. Until now, it had

Related Keywords

United States ,Stanley Erck ,Drug Administration ,Novavax Inc ,Healthday News ,Physicians Briefing ,